These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 22168978
1. [In vitro activities of clofazimine against different drug-resistant types of Mycobacterium tuberculosis]. Gui XW, Xiao HP, Hu ZY, Cui ZL, Wang J, Lu JM. Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):579-81. PubMed ID: 22168978 [Abstract] [Full Text] [Related]
2. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis]. Lu Y, Wang B, Zhao WJ, Zheng MQ, Li P, Fu L, Liang BW. Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635 [Abstract] [Full Text] [Related]
3. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates. Zhang Z, Li T, Qu G, Pang Y, Zhao Y. Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737 [Abstract] [Full Text] [Related]
4. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo]. Lu Y, Zheng MQ, Wang B, Zhao WJ, Li P, Chu NH, Liang BW. Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601 [Abstract] [Full Text] [Related]
5. [Evaluation of the mycobacterium efficacy of linezolid in vitro]. Huang HR, Yu X, Jiang GL, Dai GM, Bi ZQ, Ma Y. Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977 [Abstract] [Full Text] [Related]
7. Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China. Li G, Xu Z, Jiang Y, Liu H, Zhao LL, Li M, Xu D, Zhao X, Liu Z, Wang R, Wan K. Int J Antimicrob Agents; 2019 Nov; 54(5):642-646. PubMed ID: 31200023 [Abstract] [Full Text] [Related]
10. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB). Martins M, Viveiros M, Ramos J, Couto I, Molnar J, Boeree M, Amaral L. Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160 [Abstract] [Full Text] [Related]
17. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media. Kamala T, Herbert D, Venkatesan P, Paramasivan CN. Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493 [Abstract] [Full Text] [Related]
18. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis]. Gui XH, Xu P, Zhao M, Wang LL, Wu J, Li J, Gao Q, Mei J. Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024 [Abstract] [Full Text] [Related]
20. [Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan]. Kazumi Y, Itagaki N, Ohmori M, Wada M, Hoshino H, Mitarai S, Sugawara I, Ishikawa N, Mori T. Kekkaku; 2007 Dec; 82(12):891-6. PubMed ID: 18188977 [Abstract] [Full Text] [Related] Page: [Next] [New Search]